Litcius/Paper detail

LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features

Shuwei Zhou, Guofeng Zhou, Yang Shen, Tianyi Xia, Ben Y. Zhao, Ziying Sun, Lei Gao, Binrong Li, Weilang Wang, Shuhang Zhang, Noble Chibuike Opara, Xunjun Chen, Shenghong Ju, Yuancheng Wang

2024American Journal of Roentgenology23 citationsDOI

Abstract

BACKGROUND. LI-RADS Treatment Response Algorithm (TRA) version 2024 (v2024) introduced separate algorithms for detecting hepatocellular carcinoma (HCC) viability after radiation and nonradiation locoregional therapies (LRTs). The nonradiation algorithm incorporated MRI-based ancillary features to optionally upgrade lesions from LR-TR Equivocal to LR-TR Viable.

Topics & Concepts

MedicineAlgorithmComputer scienceHepatocellular Carcinoma Treatment and PrognosisAdvanced MRI Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies
LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features | Litcius